- 关注表位标记
- Primary Antibodies
- Recombinant Antibodies from Human Patients
- Anti-Allergen Antibodies
- 多标签控制蛋白
- Recombinant Isotype Controls
- 抗过敏原抗体
- 重组F4/80克隆CI:A3-1
- 体内研究用重组抗体
- Recombinant F4/80 Clone CI:A3-1
- Research-Grade Biosimilars
- 关注来自人类患者的重组抗体
- 同型对照
- 重组免疫球蛋白Fc结构域(Ig-Fc结构域)
- 人源性重组抗体
- 研究级生物仿制药
- 其他产品
- 抗病毒抗体
- 重组自由轻链
- Antibodies to Epitope Tags
- Anti-Virus Antibodies
UniProt Accession Number of Target Protein: P49278
Alternative Name(s) of Target: Mite group 2 allergen Der p 2; Allergen Der p II; DPXImmunogen: The antibody was generated by immunising mice with Der p 2.
Specificity: H3 binds a distinct epitope to clones H10 and H5.
Application Notes: The VH and VL sequences of H3 were used to generate a chimeric recombinant IgE antibody. The binding of chimericH3 to Der p 2 was confirmed using SPR, with a Kd value approaching 10 nM. SPR also showed it binds distinct epitopes to clones H5 and H10.
Antibody first published in:Christensen et al.Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challengeJ Allergy Clin Immunol. 2008 Aug;122(2):298-304.PMID:18572230Note on publication:Descibes the original production of the antibody and its characterisation through SPR.